» Articles » PMID: 31970498

ZBP1/DAI-Dependent Cell Death Pathways in Influenza A Virus Immunity and Pathogenesis

Overview
Date 2020 Jan 24
PMID 31970498
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza A viruses (IAV) are members of the Orthomyxoviridae family of negative-sense RNA viruses. The greatest diversity of IAV strains is found in aquatic birds, but a subset of strains infects other avian as well as mammalian species, including humans. In aquatic birds, infection is largely restricted to the gastrointestinal tract and spread is through feces, while in humans and other mammals, respiratory epithelial cells are the primary sites supporting productive replication and transmission. IAV triggers the death of most cell types in which it replicates, both in culture and in vivo. When well controlled, such cell death is considered an effective host defense mechanism that eliminates infected cells and limits virus spread. Unchecked or inopportune cell death also results in immunopathology. In this chapter, we discuss the impact of cell death in restricting virus spread, supporting the adaptive immune response and driving pathogenesis in the mammalian respiratory tract. Recent studies have begun to shed light on the signaling pathways underlying IAV-activated cell death. These pathways, initiated by the pathogen sensor protein ZBP1 (also called DAI and DLM1), cause infected cells to undergo apoptosis, necroptosis, and pyroptosis. We outline mechanisms of ZBP1-mediated cell death signaling following IAV infection.

Citing Articles

TRIF-TAK1 signaling suppresses caspase-8/3-mediated GSDMD/E activation and pyroptosis in influenza A virus-infected airway epithelial cells.

Sun Y, Yu H, Zhan Z, Liu W, Liu P, Sun J iScience. 2025; 28(1):111581.

PMID: 39811662 PMC: 11732511. DOI: 10.1016/j.isci.2024.111581.


Bat RNA viruses employ viral RHIMs orchestrating species-specific cell death programs linked to Z-RNA sensing and ZBP1-RIPK3 signaling.

Mishra S, Jain D, Dey A, Nagaraja S, Srivastava M, Khatun O iScience. 2024; 27(12):111444.

PMID: 39697597 PMC: 11652944. DOI: 10.1016/j.isci.2024.111444.


PANoptosis: a new insight for oral diseases.

Jiang X, Fu T, Huang L Mol Biol Rep. 2024; 51(1):960.

PMID: 39235684 DOI: 10.1007/s11033-024-09901-y.


The Hemagglutinin of Influenza A Virus Induces Ferroptosis to Facilitate Viral Replication.

Ouyang A, Chen T, Feng Y, Zou J, Tu S, Jiang M Adv Sci (Weinh). 2024; 11(39):e2404365.

PMID: 39159143 PMC: 11497066. DOI: 10.1002/advs.202404365.


Influenza virus infection activates TAK1 to suppress RIPK3-independent apoptosis and RIPK1-dependent necroptosis.

Sun Y, Ji L, Liu W, Sun J, Liu P, Wang X Cell Commun Signal. 2024; 22(1):372.

PMID: 39044278 PMC: 11264382. DOI: 10.1186/s12964-024-01727-2.


References
1.
Aaes T, Kaczmarek A, Delvaeye T, De Craene B, De Koker S, Heyndrickx L . Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity. Cell Rep. 2016; 15(2):274-87. DOI: 10.1016/j.celrep.2016.03.037. View

2.
Air G . Influenza neuraminidase. Influenza Other Respir Viruses. 2011; 6(4):245-56. PMC: 3290697. DOI: 10.1111/j.1750-2659.2011.00304.x. View

3.
Allen I, Scull M, Moore C, Holl E, McElvania-TeKippe E, Taxman D . The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009; 30(4):556-65. PMC: 2803103. DOI: 10.1016/j.immuni.2009.02.005. View

4.
Baccam P, Beauchemin C, Macken C, Hayden F, Perelson A . Kinetics of influenza A virus infection in humans. J Virol. 2006; 80(15):7590-9. PMC: 1563736. DOI: 10.1128/JVI.01623-05. View

5.
Balachandran S, Roberts P, Brown L, Truong H, Pattnaik A, Archer D . Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity. 2000; 13(1):129-41. DOI: 10.1016/s1074-7613(00)00014-5. View